VALLORTUS
Back to Products200 mg / ml
| Form | Suspension |
|---|---|
| Active Substance | Sodium valproate |
| Presentation | Vial 40 ml |
| Treatment Category | Nervous system |
CORPORATE
WMR&D
- WMR&D CENTER
- SCIENCE DEPARTMENT
-
PRODUCT DEVELOPMENT AND TECHNOLOGY TRANSFER
- WMINOLAB
BUSINESS STRATEGY
PRESS
-
WORLD MEDICINE IN PRESS
- PRESS RELEASES
- PRESS CENTER
- CORPORATE VIDEOS